Drugs / ZM001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06852573 | Feb 2025 → Feb 2026 overdue | systemic lupus erythematosus | Beijing Immunochina Medical Science & Technology Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ZM001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06852573 ↗ |